Indeed, in 2020, a study carried out in mice, reported that the reestablishment of IL-12 expression, involving a previous IL-4 blockade, by a new subset of regulatory DCs resulted in a tumour control, due to enhancement CD8+ T cell function [298]. Here, CD8A is linked to neoplasm.